Visgenx - Crunchbase Company Profile & Funding

Q: Where is Visgenx's headquarters?

Visgenx is located in San Diego, California, United States.

Q: Who invested in Visgenx?

Visgenx is funded by TCA Venture Group.

Q: When was the last funding round for Visgenx?

Visgenx closed its last funding round on obfuscated from a Venture - Series Unknown round.

Overview

Visgenx

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Visgenx

CB Rank

56040

Visgenx develops therapeutics to protect against the loss of sight from retinal disorders.

Founded

obfuscation

Private

Venture - Series Unknown

San Diego, California, United States

51-100

visgenxinc.com/

Biotechnology

Medical

Therapeutics

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Convertible Note

OBF

obfuscation

Key People

Christopher Chavez: Vice President, Head of Synthetic Biology
Martin Emanuele: COO and Co-Founder

Details

Legal Name

Visgenx, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Daniel Chao, Dorota Skowronska, Martin Emanuele, Santosh J. Vetticaden

About the Company

Visgenx develops therapeutics to protect against the loss of sight from retinal disorders. Its programs are based on increasing the expression of a gene known as ELOVL2 which may regulate aging in cells critical for vision.

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

ELOVL2 Gene Therapy for Dry AMD

A gene therapy designed to increase ELOVL2 expression in retinal cells to address dry age-related macular degeneration (AMD).

Synthetic AAV Non-viral Gene Delivery Platform

A synthetic vector system for gene delivery that enables large transgene delivery and reduced immunogenicity compared to viral vectors.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Visgenx	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Visgenx	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Visgenx	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Visgenx	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Visgenx	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Visgenx	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Visgenx	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Visgenx	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Visgenx	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Visgenx	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
TCA Venture Group	—	Convertible Note - Visgenx	—
TCA Venture Group	—	Convertible Note - Visgenx	—
TCA Venture Group	—	Convertible Note - Visgenx	—
TCA Venture Group	—	Convertible Note - Visgenx	—
TCA Venture Group	—	Convertible Note - Visgenx	—